Other

Amgen·Balance Sheet Statement·32 metrics

Breakdown

Loading...

Metrics

Cumulative Cost Basis

Fair Value Measurement Disclosure

Gross Assets/Liabilities

Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax

Gross Unrealized Gains

Total

Available for sale investments

Business Combination, Contingent Consideration, Liability

Common stock, par value (in dollars per share)

Common stock, shares authorized (in shares)

Common Stock, Shares, Outstanding

Debt issuances

Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

Deferred income taxes

Derivative, gross, assets

Derivatives, gross, liabilities

Finite-Lived Intangible Assets, Accumulated Amortization

2028

2030

2031

Remainder of 2026

2027

2029

Gross Carrying Amount

Identifiable Intangible Assets Accumulated Amortization

Identifiable Intangible Assets Gross

Amount outstanding under the credit facility

Syndicated, unsecured revolving credit facility capacity

Other (including finance leases)

Share Repurchase Program, Remaining Authorized, Amount

Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2025